Prevalence of Hypertrophic Cardiomyopathy in Fetuses of Mothers with Gestational Diabetes before Initiating Treatment
| Autor: | Anelise Darabas dos Santos, Jean Carl Silva, Mona Adalgisa Simões, Mariana Ribeiro e Silva, Bruna da Silva Ferreira, Carolina Rossi Palmieri |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Adult
medicine.medical_specialty Cardiomyopathy 030204 cardiovascular system & hematology fetal echocardiography 03 medical and health sciences 0302 clinical medicine Pregnancy Diabetes mellitus Internal medicine medicine Prevalence Humans reproductive and urinary physiology Fetus 030219 obstetrics & reproductive medicine heart diseases medicine.diagnostic_test Obstetrics business.industry Hypertrophic cardiomyopathy Obstetrics and Gynecology Gestational age Gynecology and obstetrics Cardiomyopathy Hypertrophic medicine.disease hypertrophic cardiomyopathy Gestational diabetes fetus Diabetes Gestational Fetal Diseases Cross-Sectional Studies embryonic structures Cardiology RG1-991 Female gestational diabetes business Fetal echocardiography |
| Zdroj: | Revista Brasileira de Ginecologia e Obstetrícia, Vol 39, Iss 1, Pp 9-13 (2017) Revista Brasileira de Ginecologia e Obstetrícia v.39 n.1 2017 Revista brasileira de ginecologia e obstetrícia Federação Brasileira das Sociedades de Ginecologia e Obstetrícia (FEBRASGO) instacron:FEBRASGO |
| ISSN: | 1806-9339 |
| Popis: | Objective To evaluate the prevalence of hypertrophic cardiomyopathy (HCM) in fetuses of pregnant women with gestational diabetes mellitus (GDM) in the beginning of the treatment. Methods A cross-sectional study was performed between July 1, 2013, and December 20, 2013, in a public maternity clinic in southern Brazil. The subjects were 63 fetuses of mothers with gestational diabetes, with a single pregnancy and no other associated pathologies. We diagnosed HCM through a fetal echocardiography before treatment and evaluated the maternal and fetal characteristics. Results The average age of the pregnant women was 32.32 (±6.2) years, and the average gestational age at the time of the evaluation was 30.59 (±2.27) weeks. The interventricular septum thickness showed a standard deviation of more than two in 50.8% of the fetuses (95% confidence interval [95%CI]: 38.1–63.5%). The left ventricular wall thickness showed a standard deviation of more than 2 in 13 (20.6%) fetuses (95%CI: 11.1–30.2%). The HCM was confirmed in 54% of the fetuses (95%CI: 41.3–65.1%). The fetal abdominal circumference was normal in 46 (73%) fetuses, and 50% of these fetuses had HCM. Conclusion The prevalence of hypertrophic cardiomyopathy in fetuses of pregnant women with GDM before treatment was of 54% (95%CI: 41.3–65.1%). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|